10,235 Shares in STERIS plc (NYSE:STE) Bought by Elo Mutual Pension Insurance Co

Elo Mutual Pension Insurance Co purchased a new stake in shares of STERIS plc (NYSE:STE) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 10,235 shares of the medical equipment provider’s stock, valued at approximately $2,104,000.

Other institutional investors have also added to or reduced their stakes in the company. Avalon Trust Co purchased a new stake in shares of STERIS during the fourth quarter worth about $30,000. Human Investing LLC bought a new position in STERIS during the 4th quarter valued at approximately $31,000. Anfield Capital Management LLC lifted its holdings in STERIS by 100.0% in the 4th quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider’s stock worth $37,000 after buying an additional 91 shares during the period. Central Pacific Bank Trust Division grew its position in shares of STERIS by 65.5% in the 4th quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider’s stock worth $39,000 after buying an additional 76 shares during the last quarter. Finally, Manchester Capital Management LLC increased its stake in shares of STERIS by 182.7% during the fourth quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider’s stock valued at $44,000 after buying an additional 137 shares during the period. Hedge funds and other institutional investors own 94.69% of the company’s stock.

STERIS Stock Performance

Shares of STERIS stock opened at $222.99 on Friday. The business has a fifty day simple moving average of $222.51 and a two-hundred day simple moving average of $221.30. The firm has a market capitalization of $21.91 billion, a P/E ratio of 47.34 and a beta of 0.92. The company has a current ratio of 2.13, a quick ratio of 1.40 and a debt-to-equity ratio of 0.32. STERIS plc has a 12 month low of $197.82 and a 12 month high of $248.24.

STERIS (NYSE:STE) last posted its quarterly earnings data on Wednesday, February 5th. The medical equipment provider reported $2.32 EPS for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. On average, equities analysts forecast that STERIS plc will post 9.08 earnings per share for the current fiscal year.

STERIS Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 21st. Shareholders of record on Thursday, February 20th were paid a dividend of $0.57 per share. This represents a $2.28 dividend on an annualized basis and a yield of 1.02%. The ex-dividend date of this dividend was Thursday, February 20th. STERIS’s payout ratio is 48.41%.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on the stock. JMP Securities reiterated a “market outperform” rating and issued a $265.00 price target on shares of STERIS in a report on Thursday, February 6th. Stephens reaffirmed an “overweight” rating and set a $240.00 target price on shares of STERIS in a research note on Thursday, February 6th. Finally, Piper Sandler boosted their price target on shares of STERIS from $260.00 to $265.00 and gave the company an “overweight” rating in a research report on Monday, February 3rd. One research analyst has rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to data from MarketBeat, STERIS has a consensus rating of “Moderate Buy” and an average target price of $258.75.

STERIS Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.